Special Issues
Improvements in HPLC column technology continue. Since the last Special Supplement on columns in 2008 (1), the continued need for high-throughput separation, the encountering of more complex samples, the need to analyze very polar compounds more easily, and the increased availability of very high pressure instruments has placed additional demands on the HPLC column. In terms of high throughput, no less than 24 companies have responded and have developed small particle columns of 2 µm and under. In addition, the number of superficially porous particle (SPP) columns has expanded, and users are finding that the high-efficiency-at-low-pressure advantage brings them added advantages. With more complex samples, longer columns packed with sub-2-µm particles require higher pressures with pumps now available to 1300 bar. It will be of interest to see if the lower pressure, high-efficiency SPP columns and monoliths, the latter of which have seen advances in the research of polymeric monoliths for applications to..
Improvements in HPLC column technology continue. Since the last Special Supplement on columns in 2008 (1), the continued need for high-throughput separation, the encountering of more complex samples, the need to analyze very polar compounds more easily, and the increased availability of very high pressure instruments has placed additional demands on the HPLC column. In terms of high throughput, no less than 24 companies have responded and have developed small particle columns of 2 µm and under. In addition, the number of superficially porous particle (SPP) columns has expanded, and users are finding that the high-efficiency-at-low-pressure advantage brings them added advantages. With more complex samples, longer columns packed with sub-2-µm particles require higher pressures with pumps now available to 1300 bar. It will be of interest to see if the lower pressure, high-efficiency SPP columns and monoliths, the latter of which have seen advances in the research of polymeric monoliths for applications to small molecules, will be the direction that chromatographers go to keep column pressures reasonable. To solve complex separations, a great deal of interest has been created around comprehensive LC×LC, where the first dimension is carried out on a slower but orthogonal column to the second dimension. The development of more orthogonal columns to provide better resolution is underway and instrumentation that can conveniently perform such experiments is beginning to appear. The pressure race among leading instrumentation companies appears to be in full swing but column capability might still tax the extracolumn effects as columns continue to become more efficient with smaller volumes. Automated instruments for method development and walk-up LC–MS systems have come into their own to make method development easier.
Ronald E. Majors
Although reversed-phase chromatography is still king, the increasing use of hydrophilic interaction liquid chromatography (HILIC) for polar compounds only slightly or unretained on typical reversed-phase columns has been seen. More columns for chiral recognition have been introduced as some patents on more popular technologies have expired.
To update LCGC readers, I have assembled an excellent selection of HPLC column experts to bring us up-to-date in specific areas of column technology. First, I will discuss some of the innovations that have occurred and are occurring in reversed-phase chromatography. Frantisek Svec will update the tremendous progress being made in monolith technology, while Chris Pohl highlights columns for ion-exchange and ion chromatography focusing on small molecules. Next, Tom Beesley, an early worker in the field of chiral separations, will discuss chiral columns and some new chemistries. David Carr, who has worked in HPLC for nearly 40 years, will discuss biocolumns, an area where he has considerable experience. Finally, Matthias Pursch will discuss automated method development and show some examples of "real world" industrial applications. I do hope that you enjoy this Special Supplement and find something of interest and value. Good reading.
(1) "Recent Developments in LC Column Technology" LCGC North America S26 (S4), April 2008.
Ronald E. Majors
Recent Developments in
LC Column Technology Editor
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.